POLE

POLE, DNA polymerase epsilon, a key player in DNA replication, is responsible for appending nucleotides at the replication fork and maintaining replication fidelity through its proofreading capability. The exonuclease domain of this enzyme is tasked with identifying and removing mismatched nucleotides. However, alterations within the POLE gene, particularly affecting the exonuclease domain, can result in uncorrected replication mistakes, thereby increasing the mutation rate and the risk of cancer development. Such genetic variations are linked to the onset of various cancers, such as endometrial, colorectal, and non-small cell lung cancers. Tumors with POLE mutations, characterized by their high mutational load, may present new antigens on their surface, rendering them suitable for immunotherapeutic approaches. Detecting POLE mutations is vital for tumor diagnosis, prognosis evaluation, and the selection of optimal treatment strategies.